UBS maintains Cerebras Systems at Buy, lowers price target to $250 from $330

What happened

UBS kept its Buy rating on Cerebras Systems but cut its price target to $250 from $330, a 24.2% decrease. The new target implies 159.4% upside from the Nov 2 close of $96.36.

Confirmed

Global impact / market context

A lower target means UBS still expects the stock to rise but sees less room than before, so future profit expectations may have been trimmed. Investors who use analyst targets to judge possible gains get a less optimistic guidepost while the Buy rating stays.

Analyst inference

The target sits far above the $96.36 close, so UBS still sees large potential upside even after the cut. Other analyst targets and ratings for Cerebras could show whether this reduction is isolated or part of a broader reset.

Analyst inference

What to watch

1. UBS lowered the Cerebras price target to $250 from $330 while keeping a Buy rating, a 24.2% decrease. Confirmed
2. Watch whether other analysts also reduce their Cerebras price targets, which would suggest a wider reset of profit expectations. Proposed
3. Track Cerebras revenue and costs in coming reports; weaker results could explain a lower target and pressure the stock toward $96.36. Analyst inference

Evidence

• Original source link unavailable